TcLand Expression http://www.tcland-expression.com Wed, 22 Jun 2011 08:54:28 +0000 en hourly 1 http://wordpress.org/?v=3.0.1 TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis http://www.tcland-expression.com/tcland-expression-will-receive-1-2-million-euros-from-oseo-and-erdf-to-support-a-leading-project-in-personalised-medicine-focused-on-rheumatoid-arthritis/ http://www.tcland-expression.com/tcland-expression-will-receive-1-2-million-euros-from-oseo-and-erdf-to-support-a-leading-project-in-personalised-medicine-focused-on-rheumatoid-arthritis/#comments Fri, 17 Jun 2011 07:30:17 +0000 admin http://www.tcland-expression.com/?p=770 Continue reading →]]> The biotech company TcLand Expression is pleased to announce the financial support awarded by Oseo and the European Regional Development Fund (ERDF) for the validation study of the first companion diagnostic test in rheumatoid arthritis. The program is mainly dedicated to setting up a prospective European multicentre clinical trial to validate the diagnostic performance of a molecular test to predict non-response to anti-TNF treatment (in particular infliximab Remicade®) in Rheumatoid Arthritis patients. EN.

La société TcLand Expression est heureuse d’annoncer le financement, par Oséo et le Fond Européen de Développement Régional (FEDER), de son programme de validation des performances cliniques du premier diagnostic compagnon dans la polyarthrite rhumatoïde. Le support d’Oséo, avec l’appui du FEDER, porte essentiellement sur la réalisation d’un essai prospectif multicentrique européen de validation des performances cliniques du test RA-INF-Dx. Ce test est un outil d’aide à l’identification de patients souffrant de polyarthrite rhumatoïde et susceptibles de ne pas répondre à un traitement par un anti-TNF : l’infliximab (Remicade ®). FR.

]]> http://www.tcland-expression.com/tcland-expression-will-receive-1-2-million-euros-from-oseo-and-erdf-to-support-a-leading-project-in-personalised-medicine-focused-on-rheumatoid-arthritis/feed/ 0 TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member http://www.tcland-expression.com/tcland-expression%e2%80%99s-board-of-directors-appoints-highly-qualified-personalized-medicine-expert-felix-frueh-phd-as-new-board-member/ http://www.tcland-expression.com/tcland-expression%e2%80%99s-board-of-directors-appoints-highly-qualified-personalized-medicine-expert-felix-frueh-phd-as-new-board-member/#comments Tue, 19 Apr 2011 07:32:38 +0000 admin http://www.tcland-expression.com/?p=747 Continue reading →]]> TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine today announced the appointment of Felix Frueh PhD, as new member of the company’s Board of Directors. EN.

TcLand Expression SA, société leader dans le domaine des biomarqueurs d’expression de gènes en immunologie et médecine personnalisée annonce aujourd’hui la nomination du Dr. Felix Frueh, en tant que nouveau membre de son conseil d’administration. FR.

]]> http://www.tcland-expression.com/tcland-expression%e2%80%99s-board-of-directors-appoints-highly-qualified-personalized-medicine-expert-felix-frueh-phd-as-new-board-member/feed/ 0 TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology http://www.tcland-expression.com/tcland-expression-is-part-of-the-innovative-medicines-initiative-%e2%80%9cbe-the-cure%e2%80%9d-the-largest-european-consortium-for-rheumatology/ http://www.tcland-expression.com/tcland-expression-is-part-of-the-innovative-medicines-initiative-%e2%80%9cbe-the-cure%e2%80%9d-the-largest-european-consortium-for-rheumatology/#comments Tue, 22 Mar 2011 15:12:57 +0000 admin http://www.tcland-expression.com/?p=710 Continue reading →]]> TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine, today is pleased to announce its participation in the Innovative Medicines Initiative (IMI) project “Be The CURE”.EN.

TcLand Expression est heureux d’annoncer sa participation au projet “Be The Cure”, sélectionné dans le cadre du second appel à projet de l’IMI (Innovative Medicines Initiative).FR.

]]> http://www.tcland-expression.com/tcland-expression-is-part-of-the-innovative-medicines-initiative-%e2%80%9cbe-the-cure%e2%80%9d-the-largest-european-consortium-for-rheumatology/feed/ 0 TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient http://www.tcland-expression.com/tcland-expression-launches-the-print-international-clinical-trial-to-validate-its-blood-biomarker-ra-inf-dx-and-announces-the-recruitment-of-its-first-patient/ http://www.tcland-expression.com/tcland-expression-launches-the-print-international-clinical-trial-to-validate-its-blood-biomarker-ra-inf-dx-and-announces-the-recruitment-of-its-first-patient/#comments Mon, 21 Feb 2011 21:00:43 +0000 admin http://www.tcland-expression.com/?p=652 Continue reading →]]> TcLand Expression launches the “PRINT” international clinical trial to
validate its blood biomarker RA-INF-Dx and announces the recruitment of
its first patient

TcLand Expression annonce la mise en place de « PRINT », étude clinique
internationale de validation de son marqueur sanguin RA-INF-Dx et le premier patient recruté

]]> http://www.tcland-expression.com/tcland-expression-launches-the-print-international-clinical-trial-to-validate-its-blood-biomarker-ra-inf-dx-and-announces-the-recruitment-of-its-first-patient/feed/ 0 TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition http://www.tcland-expression.com/tcland-expression-nominated-as-a-featured-member-of-the-us-personalized-medicine-coalition/ http://www.tcland-expression.com/tcland-expression-nominated-as-a-featured-member-of-the-us-personalized-medicine-coalition/#comments Mon, 31 Jan 2011 08:38:43 +0000 admin http://www.tcland-expression.com/?p=644 TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition

TcLand Expression distinguée comme membre emblématique de la “Personalized Medicine Coalition”

]]> http://www.tcland-expression.com/tcland-expression-nominated-as-a-featured-member-of-the-us-personalized-medicine-coalition/feed/ 0 Scientific and Medical Advisory Board dedicated to Rheumatology http://www.tcland-expression.com/scientific-and-medical-advisory-board-dedicated-to-rheumatology/ http://www.tcland-expression.com/scientific-and-medical-advisory-board-dedicated-to-rheumatology/#comments Thu, 13 Jan 2011 08:31:29 +0000 admin http://www.tcland-expression.com/?p=619 TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology ]]> http://www.tcland-expression.com/scientific-and-medical-advisory-board-dedicated-to-rheumatology/feed/ 0 Peter Payne appointed as Chief Business Officer and Head of US Operations http://www.tcland-expression.com/peter-payne-appointed-as-chief-business-officer-and-head-of-us-operations/ http://www.tcland-expression.com/peter-payne-appointed-as-chief-business-officer-and-head-of-us-operations/#comments Mon, 20 Dec 2010 09:26:47 +0000 admin http://www.tcland-expression.com/?p=564 Continue reading →]]> TcLand Expression strengthens its senior management team by appointing Peter Payne as Chief Business Officer and Head of US Operations.

TcLand Expression renforce son équipe dirigeante senior avec la nomination de Peter Payne en tant que Directeur du Business Développement (CBO) et responsable des opérations Nord Américaines

]]> http://www.tcland-expression.com/peter-payne-appointed-as-chief-business-officer-and-head-of-us-operations/feed/ 0 First EPEMED conference http://www.tcland-expression.com/first-epemed-conference/ http://www.tcland-expression.com/first-epemed-conference/#comments Wed, 20 Oct 2010 14:39:45 +0000 admin http://www.tcland-expression.com/testsite/?p=283 EPEMED, European personalized medicine Association organized its first conference in Paris. FR.

]]> http://www.tcland-expression.com/first-epemed-conference/feed/ 0 Licensing agreement with Inserm Transfert http://www.tcland-expression.com/licensing-agreement-with-inserm-transfert/ http://www.tcland-expression.com/licensing-agreement-with-inserm-transfert/#comments Tue, 27 Jul 2010 14:35:43 +0000 admin http://www.tcland-expression.com/testsite/?p=279 TcLand Expression signs a licensing agreement with Inserm Transfert and initiates a strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies. EN. FR.

]]> http://www.tcland-expression.com/licensing-agreement-with-inserm-transfert/feed/ 0 Major new partnership with research institute http://www.tcland-expression.com/major-new-partnership-with-research-institute/ http://www.tcland-expression.com/major-new-partnership-with-research-institute/#comments Tue, 29 Jun 2010 14:34:46 +0000 admin http://www.tcland-expression.com/testsite/?p=277 TcLand Expression initiates major partnership with the Hospital Vall d’Hebron Research Institute and gets exclusive rights on key intellectual property in the field of novel biomarkers in rheumatoid arthritis. EN. FR.

]]> http://www.tcland-expression.com/major-new-partnership-with-research-institute/feed/ 0